Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.
作者信息
UNGAR J, MUGGLETON P W, DUDLEY J A, GRIFFITHS M I
出版信息
Br Med J. 1962 Oct 27;2(5312):1086-9. doi: 10.1136/bmj.2.5312.1086.
Abstract
摘要
相似文献
1
Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.
Br Med J. 1962 Oct 27;2(5312):1086-9. doi: 10.1136/bmj.2.5312.1086.
2
Freeze-dried B.C.G. vaccine; methods adopted in preparation of a standard product.
Br Med J. 1956 Sep 8;2(4992):568-71. doi: 10.1136/bmj.2.4992.568.
3
Multiple-puncture vaccination with freeze-dried B.C.G. vaccine in schoolchildren.
Br Med J. 1961 Feb 25;1(5225):536-40. doi: 10.1136/bmj.1.5225.536.
4
Liquid or freeze-dried B.C.G. vaccine. Persistence of tuberculin sensitivity in schoolchildren after vaccination.
Br Med J. 1961 Nov 18;2(5263):1322-4. doi: 10.1136/bmj.2.5263.1322.
5
BCG-vaccination with freeze-dried vaccine.
Acta Tuberc Scand. 1952;27(1-2):76-83.
6
A freeze-dried vaccine from isoniazid-resistant B.C.G. A clinical investigation.
Br Med J. 1961 May 27;1(5238):1500-1. doi: 10.1136/bmj.1.5238.1500.
7
Freeze-dried B.C.G. vaccine from an isoniazid-resistant strain. A laboratory investigation.
Br Med J. 1961 May 27;1(5238):1498-500. doi: 10.1136/bmj.1.5238.1498.
8
Multiple-puncture vaccination in the newborn with freeze-dried B.C.G. vaccine.
Br Med J. 1960 Oct 15;2(5206):1116-9. doi: 10.1136/bmj.2.5206.1116.
9
[Antituberculous vaccination with freeze dried BCG vaccine. I. Properties of the dry BCG vaccine].
Gruzlica (1926). 1955 Jan;23(1):1-11.
10
The use of a synthetic ester of oleic acid ('Tween 80') in the preparation of freeze-dried BCG vaccines; a preliminary report.
Tubercle. 1951 Nov;32(11):251-3. doi: 10.1016/s0041-3879(51)80044-8.
引用本文的文献
1
Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.
Eur J Pharm Biopharm. 2013 Oct;85(2):279-86. doi: 10.1016/j.ejpb.2013.03.029. Epub 2013 Apr 10.
2
B.C.G. BY JET INJECTOR.
Br Med J. 1965 Aug 21;2(5459):434-5.
3
Galactosamine in walls of slow-growing mycobacteria.
Biochem J. 1997 Oct 15;327 ( Pt 2)(Pt 2):519-25. doi: 10.1042/bj3270519.
4
Serial subcultivation of Czechoslovakian and Japanese BCG strains.
J Hyg (Lond). 1980 Oct;85(2):235-46. doi: 10.1017/s0022172400063270.
5
Activation of the alternative pathway of complement by mycobacteria and cord factor.
Infect Immun. 1980 Jul;29(1):30-5. doi: 10.1128/iai.29.1.30-35.1980.
6
Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
Cancer Immunol Immunother. 1984;17(1):18-27. doi: 10.1007/BF00205492.
7
A co-operative evaluation of test systems used to assay tuberculosis vaccines.
Bull World Health Organ. 1971;45(5):543-50.
8
Size characterization of Mycobacterium bovis BCG (Bacillus Calmette Guérin) vaccine, Tice substrain.
Pharm Res. 1988 Sep;5(9):607-10. doi: 10.1023/a:1015954316139.
9
High-viability lyophilized Bacille Calmette-Guérin vaccine produced by deep-culture technique.
Appl Environ Microbiol. 1977 Nov;34(5):495-9. doi: 10.1128/aem.34.5.495-499.1977.
本文引用的文献
1
Effect of adjuvant on preservability of dried BCG vaccine at 37 degrees C.
Bull World Health Organ. 1956;14(4):657-69.
2
Freeze-dried B.C.G. vaccine; methods adopted in preparation of a standard product.
Br Med J. 1956 Sep 8;2(4992):568-71. doi: 10.1136/bmj.2.4992.568.
3
Freezedried B.C.G.; vaccination of newborn infants with a British vaccine.
Br Med J. 1956 Sep 8;2(4992):565-8. doi: 10.1136/bmj.2.4992.565.
4
Studies on the stability of lyophilized B C G vaccine.
Yale J Biol Med. 1953 Feb;25(4):262-83.
Zotero 插件